Suzuken Co., Ltd. announces an Equity Buyback for 6,000,000 shares, representing 7.25% for ¥25,000 million.
November 10, 2023 at 01:00 am EST
Share
Suzuken Co., Ltd. (TSE:9987) announces a share repurchase program. Under the program, the company will repurchase up to 6,000,000 shares, representing 7.25% of its total shares outstanding (excluding treasury shares), for a total of ¥25,000 million. The purpose of repurchase program is to implement flexible capital policies that respond to changes in the business environment.
The repurchase program is valid till March 8, 2024. As of October 31, 2023, the company had 82,765,841 shares outstanding (excluding treasury shares) and had 66,063 shares in treasury.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
